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Pulmonary Morphologist — Opportuni ty for Ph.D. or M.D. for ap-
pointment as Assistant or Associate Professor (research) in the In-
stitute for Environmental Medicine and the Depar tment of Pathol-
ogy and Laboratory Medicine at the University of Pennsylvania 
School of Medicine. Successful candidate will collaborate with es-
tablished investigators in respiratory physiology/experimental 
pathology and will develop an independent research program in 
respiratory cell biology. Experience with electron microscopy is es-
sential. Ample space, funding opportunit ies, and state-of-the-art 
facilities are available. Deadline for applications is December 31, 
1985. Interested applicants should send C.V., statement of research 
interests, and names of three references to Aron B. Fisher, M.D., 
Director, Institute for Environmental Medicine, Chairman, Pulmo-
nary Morphology Search Committee, University of Pennsylvania 
School of Medicine/G2, Philadelphia, PA 19104. The University 
of Pennsylvania is an equal opportunity/affirmative action employer. 
Pulmonologist: Board certified or eligible to join expanding 2-man 
group in midwest city with large university. Must be proficient in 
all aspects of pulmonary and critical care medicine and be willing 
to do some internal medicine. Please reply with C.V. to Box 575. 
Pulmonary physician sought to join pulmonary division of a major 
Canadian university hospital. Candidate must be experienced and 
capable of conducting independent clinical or basic research. Reply 
Box 583. 
Pulmonologist/Internist, require BE/BC-pu lmona ry . N.Y.C. sub-
urb, active ICU, office consultation, 80% pulmonary, PVT prac-
tice, teaching affiliations. Proficient all procedures. Available now 
or July 1986. Reply Box 582. 
Postdoctoral Research Fellowships in Lung Research for 1985-86 
and 1986-87 available in the University of California, Davis (UCD) 
Interdisciplinary Pulmonary Disease Research Group. Ph.D., M.D., 
or DVM required. Ongoing research areas include nutritional aspects 
of lung disease, alveolar macrophage cytochemistry, respiratory gly-
coprotein biosynthesis and metabolism, lung collagen and elastin, 
lung liposomes and lipoprotein metabolism, airway nerves and blood 
supply, relationships of xenobiotic metabolism to pulmonary cyto-
toxicity, mechanism of respiratory epithelial differentiation, respira-
tory tract permeability, and inhalation toxicology. Eight U C D faculty 
with research activities in lung disease involved in fellowship train-
ing program. Send resume to: Dr. C. E. Cross, Division of Pu lmo-
nary Medicine, 4301 "X" St., University of California, Davis Medi-
cal Center, Sacramento, CA 95817. Equal Oppor tuni ty /Aff i rma-
tive Action Institution. 
Practice for sale: Pu lmonary and Internal Medicine. Active prac-
tice for 11 years. Nice Chicago suburban location. Practice includes 
office building, fully equipped office. Will introduce. Reply to Box 
584. 
Pulmonologist —To join 7 internists in 20-man multispeciality group. 
Must be able to practice excellent general internal medicine as well. 
City of 32,000 with 2 hospitals, serving area of 200,000. No pu lmo-
nologist in area. Attractive family environment, nearby lake, con-
venient to Twin Cities. Send C.V. to Administrator, Park Clinic, 890 
North Eisenhower, Mason City, IA 50401. 
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histamine-induced reflex tracheal constriction is exaggerated 
by, 287 
Immune 
complexes and complement abnormalities in patients with cystic 
fibrosis, 770 
responsiveness, local pulmonary, after multiple antigenic ex-
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in hamsters, 358 
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boxane synthetase inhibitor, on, in unanesthetized sheep, 
494 
hyperoxic, and polyamine biosynthesis, age-related differ-
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and pyrazinoic acid alone and in combinat ion, 1274 
mouse 
alveolar, IgA-mediated phagocytosis by, 82 
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1396 SUBJECT INDEX 
in rat, 880 
Monkey 
cynomologus, local pulmonary immune responsiveness after 
multiple antigenic exposure in, 657 
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and D 4 , prostaglandin F 2 a , and potassium, nifedipine 
inhibits, 299 
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pyrazinoic acid alone and in combination, 1274 
Mycobacterium 
avium-in tracellulare-scrofulaceum 
complex, phage typing of, 386 
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resistance, dynamic components of, 1229 
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amphoter ic in B causes aggregation of, 602 
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differential inhibition of bronchoconstriction by, 666 
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with pulmonary hypertension secondary to COPD, 963 
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by leukotrienes C4 and D4 , prostaglandin F 2 a , and potas-
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dioxide, acute effects of 0.12 ppm of, and 0.12 ppm ozone on 
pulmonary function in healthy and asthmatic adolescents, 
644 
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and mortality, 115 
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chest wall oscillation, 350 
Normocapnia , stable, during high-frequency body surface oscilla-
tion in rabbits, 104 
Nutrition and chronic lung disease (state of art), 1347 
Ofloxacin (DL 8280), antituberculosis activity of, on experimen-
tal tuberculosis in mice (Note), 915 
OKY-046, effects of, on endotoxin-induced lung injury in un-
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Oncogenes, growth factors, and lung cancer (commentary), 178 
Oophorectomy and progesterone, successful treatment of pul-
monary lymphangiomyomatosis with (case report), 916 
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and air, ventilatory muscle function during exercise in, in pa-
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-induced lung injury, role of, in dissemination of Pseudomonas 
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with hypoxia and C 0 2 retention caused by chronic bron-
chitis and emphysema, 206 
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acute effect of 0.12 ppm, or 0.12 ppm nitrogen dioxide on pul-
monary function in healthy and asthmatic adolescents, 648 
exposure, 0.12 ppm, respiratory responses to vigorously exer-
cising children to, 875 
-induced bronchial hyperreactivity in guinea pigs is abolished by 
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response relationship in healthy nonsmokers, 36 
Parenchyma, lung, a dynamic matrix (Amberson lecture), 1324 
PC2 0 , slope of dose-response curve to inhaled histamine a n d 
methacholine and, in subjects with symptoms of airway 
hyperexcitability, 644 
Pectus excavatum, rib cage mobility in, 1223 
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Phonopneumography, effect of anticholinergic treatment on post-
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Plasma kinetics, tritiated digoxin, influence of hypoxemia on, in 
conscious dog, 504 
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modifying enzyme assays, 409 
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posure to 100 and 8 5 % 0 2 , 548 
Pleural effusions, relationship of, to pulmonary hemodynamics in 
patients with congestive heart failure, 1253 
Pneumoconiosis, prevalence of radiographic appearance of, in 
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Pneumocystis carinii 
radiographically simulating tuberculosis, 1124 
utility of gallium-67 scintigraphy and bronchial washings in 
diagnosis and treatment of, in patients with AIDS, 1087 
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focal, serologic diagnosis of, caused by Cryptococcus neofor-
mans (case report), 189 
Pneumocystis carinii 
radiographically simulating tuberculosis, 1124 
utility of gallium-67 scintigraphy and bronchial washings 
in diagnosis and treatment of, in patients with AIDS, 1087 
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chronic hypersensitivity, cyclosporine immunomodula t ion in 
rabbit model of, 1027 
diagnostic yield of bronchoalveolar lavage in, occurring after 
allogenic bone marrow transplantation, 1118 
hypersensitivity, comparative analysis of inflammatory and 
immunocompetent cells in patients with, 400 
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Polyamine biosynthesis and hyperoxic lung injury, age-related 
differences in, 354 
Polymorphonuclear leukocyte responsiveness, effect of procaterol 
treatment on, 1194 
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lavage in, 1066 
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consumption during reduction of oxygen delivery by, 788 
Potassium, nifedipine inhibits bronchial smooth muscle contractions 
induced by, 299 
Prednisone 
inhibits late asthmatic reactions and associated increase in air-
way responsiveness induced by toluene-diisocyanate in sensi-
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therapy, airway reversibility after, in chronic asthma is as-
sociated with alterations in leukocyte function, 1199 
Procaterol treatment, effect of, on beta-adrenergic bronchodilation 
and polymorphonuclear leukocyte responsiveness, 1194 
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lymphangiomyomatosis with (case report), 916 
Propranolol , pulmonary extraction of, in patients with ARDS, 
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of hypoxic pulmonary vasoconstriction, 99 
1397 
Prostaglandin(s) 
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release and neural control, role of, in limited maximal airway 
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induced by, 299 
Protease-antiprotease hypothesis, current assessment of, in elas-
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exchange and pulmonary transvascular fluid after th rombin-
induced microembolism, 70 
pure, studies with, and evidence that Pseudomonas aeruginosa 
elastase does not inactivate bronchial inhibitor in presence 
of leukocyte elastase, 524 
Proteoglycan synthesis, growth and differentiation of nasal epi-
thelial cells in serum-free, hormone-supplemented medium 
and, 311 
Proteolysis and pulmonary emphysema (editorial), 205 
Proteolytic destruction of lung connective tissue, biochemical 
and pathologic evidence for, in cystic fibrosis, 529 
Pseudomonas aeruginosa 
dissemination of, during lung infection in hamsters, 358 
elastase does not inactivate bronchial inhibitor in presence 
leukocyte elastase, 524 
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circulation, politics (editorial), 1152 
disease, chronic obstructive 
airway reactivity in, 30 
determinants of maximal inspiratory pressure in, 42 
effects of acute bronchoconstriction on respiratory activity 
in patients with, 722 
increases in intrathoracic pressure do not explain rise in left 
ventricular end-diastolic pressure that occurs during exer-
cise in patients with, 623 
nifedipine dilates pulmonary vasculature without producing 
symptomatic systemic hypotension in upright resting and 
exercising patients with pulmonary hypertension secondary 
to, 963 
prevalence and nature of bronchial hyperresponsiveness in, 25 
respiratory 
pressure sensation and its relation to changes in breathing 
pattern and Pco2 during acute increase in airway resistance 
in patients with, 1214 
sensation in, 954 
responses to large doses of salbutamol and theophylline in 
patients with, 871 
function 
acute effects of 0.12 ppm ozone or 0.12 ppm nitrogen dioxide 
on, in healthy and asthmatic adolescents, 648 
and peripheral airway disease in patients with mineral dust 
or fume exposure, 1294 
in relation to total dust exposure at Bauxite refinery and 
alumina-based chemical products plant, 1174 
mechanics, effects of fish-oil-enriched diet on, during ana-
phylaxis, 1204 
transvascular fluid and protein exchange after thrombin-induced 
microembolism, 70 
vascular tone, effects of eicosanoid synthesis inhibitors on, 
in dogs, 93 
Pyrazinamide 
killing of macrophage-ingested mycobacteria by, 1274 
penetration of, into mouse macrophages, 1268 
Pyrazinoic acid 
killing of macrophage-ingested mycobacteria by, 1274 
penetration of, into mouse macrophages, 1268 
Rabbit(s) 
acute cigarette smoke exposure increases alveolar permeabili ty 
in, 321 
alveolar macrophages, newborn, are deficient in two micro-
bicidal cationic peptides, MCP-1 and MCP-2, 901 
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model of chronic hypersensitivity pneumoni t is , cyclosporine 
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lation in, 104 
structure-function correlation of early stages of lung injury 
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Ragweed-sensitized dogs, inbred, airway responsiveness to inhaled 
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induced by cobra venom factor in, 1288 
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in, 880 
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collagen accumulation, prevention by zinc of, in carbon tetra-
chloride injury, 536 
pat terns of accumulat ion of platelets and neutrophils in, 
dur ing exposure to 100 and 8 5 % 0 2 , 548 
regenerating, t iming of quanti tat ive recovery in, 777 
modification by hyperoxia in vivo of endotoxin-induced neu-
trophil alveolitis in, 152 
protection against pulmonary oxygen toxicity in, by intratracheal 
administrat ion of l iposome-encapsulated superoxide dis-
mutase or catalase, 164 
pu lmonary clearance of " m T c D T P A , cigarette-smoke-induced 
changes in, 1170 
Respiration, cont inuous, effects of swallowing pattern of, in 
adults , 1219 
Respiratory 
activity, effects of acute bronchoconstr ict ion on, in patients with 
C O P D (correspondence), 722 
disturbances, sleep-related, sleep-wake complaints in patients 
with, 520 
effects of photochemical oxidant air pollution in exercising 
adolescents, 619 
impedance measurements, upper airway artifact in (Note), 712 
pressure sensation and its relation to changes in breathing pat-
tern and Pco 2 during acute increase in airway resistance 
in C O P D , 1214 
responses of vigorously exercising children to 0.12 ppm ozone 
exposure, 875 
secretions, rhesus monkey, immunohis tochemical characteriza-
tion of, using monoclonal ant ibodies, 556 
sensation in C O P D , 954 
Rhinovirus infection, experimental , exacerbations of asthma in 
adults during, 976 
Rib cage 
and abdominal displacements, contr ibut ions of, to hyperinfla-
tion of acute bronchospasm, 679 
mechanics in simulated d iaphragmat ic paralysis, 793 
mobility in pectus excavatum, 1223 
motion, relationship between respiratory muscle electromyogram 
and, in tetraplegia, 53 
Rifabutine, dynamic aspects of in vitro chemotherapeut ic activity 
of, on M. intracellular, 1278 
Rifampicin 
killing of macrophage-ingested mycobacteria by, 1274 
penetrat ion of, into mouse macrophages , 1268 
R P M or RCF? (correspondence), 1371 
Salbutamol, responses to large doses of, in patients with COPD, 871 
Sarcoidosis 
comparative analysis of inf lammatory and immunocompetent 
cells in patients with, 400 
pulmonary 
immunocompetent cells in bronchoalveolar lavage reflect cell 
populations in transbronchial biopsies in, 1300 
prediction of therapeutic response in steroid-treated, 65 
steroid-treated pulmonary, prediction of therapeutic response 
in (correspondence), 1139 
T-lymphocyte subsets and immunoglobul in concentrat ions in 
bronchoalveolar lavage of patients with, 1060 
Scans 
abnormal , ventilation in middle-aged smokers, 148 
gallium-67 
lung, evaluation of, in prediction of therapeutic response in 
steroid-treated pulmonary sarcoidosis, 65 
value of, in pulmonary tuberculosis, 746 
Scintigraphy, gallium-67, utility of, in diagnosis and treatment 
of Pneumocystis carinii pneumonia in patients with 
AIDS, 1086 
Sea urchins to chromosomes and cancer, from (editorial), 935 
Sepsis, pneumococcal, alcoholism, and leukopenia, 757 
Serotonin 
levels, increased lung, relationship of, to endotoxin-induced 
pulmonary hypertension in sheep, 1257 
pulmonary extraction of, in patients with ARDS, 479 
Serum 
alpha-l-proteinase inhibitor, smoking does not reduce functional 
activity of, 818 
angiotensin-converting enzyme levels, evaluation of, in predic-
tion of therapeutic response in steroid-treated pulmonary 
sarcoidosis, 65 
antiproteases in smokers and nonsmokers , 1162 
samples from patients with ARDS, neutral endopept idase in, 
compared with angiotensin-converting enzyme, 1262 
usefulness of tumor markers in, of patients undergoing fiber-
optic bronchoscopy, 60 
Sheep 
influence of alveolar oxygen on pulmonary vasoconstriction in 
newborn lambs versus, 326 
relationship of increased lung serotonin levels to endotoxin-
induced pulmonary hypertension, 1257 
unanesthetized, effects of OKY-046, a selective thromboxane syn-
thetase inhibitor, on endotoxin-induced lung injury in, 494 
Single-breath diffusing capacity, reference equat ions for, 806 
Sleep apnea. See Apnea 
Sleep 
breathing 
during, in patients with interstitial lung disease, 224 
and oxygenation during, are similar in normal men and nor-
mal women, 86 
deprivation, effect of, on activity of genioglossus, 1242 
effects of nasal anesthesia on breathing during, 972 
respiratory muscle activity and thoracoabdominal motion dur-
ing acute episodes of as thma during, 999 
-wake complaints in patients with sleep-related respiratory dis-
turbances, 520 
Smoke 
cigarette 
augmentat ion of elastase-induced emphysema by, 885 
changes in rat pulmonary clearance of " m T c D T P A induced 
by, 1170 
exposure, acute, increases alveolar permeabili ty in rabbits , 
321 
impairs elastin resynthesis in lungs of hamsters with elastase-
induced emphysema, 640 
tobacco, pattern of inhalation of, in pipe, cigarette, and never 
smokers, 628 
Smokers 
abnormal ventilation scans in middle-aged, 148 
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asymptomatic, disassociation in mucociliary function of cen-
tral and peripheral airways of, 633 
loss of alveolar a t tachments in, 894 
nor.-, domain spirogram indices and their variability and ref-
erence values in, 1041 
and nonsmokers , serum antiproteases in, 1162 
patterns of spirogram abnormal i ty in, 1034 
Smoking 
cigarette, and health (ATS statement) , 1133 
does not reduce function activity of serum alpha-l-proteinase 
inhibitor, 818 
and nonsmoking asbestos-exposed workers, lung function and 
exercise performance in, 612 
Snoring subjects with and without obstructive sleep apnea, 
pharyngeal compliance in, 211 
Spirogram(s) 
abnormality, patterns of, in smokers, 1034 
how many, for a histamine challenge? 268 
indices, domain , variability and reference values in nonsmok-
ers of, 1041 
Spirometry 
effect of anticholinergic t reatment on postexertional wheezing 
in as thma studied by phonopneumography and, 16 
standards effects of, on two occupat ional cohorts, 120 
Sputum, cystic fibrosis, aminoglycoside penetration, inactivation, 
and efficacy in, 761 
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Bronchopulmonary dysplasia: unresolved neonatal acute lung 
injury, 694 
Elastases and emphysema: current assessment of protease-anti-
protease hypothesis, 417 
Nutrition and chronic lung disease, 1347 
Steroid 
therapy, long-term, in vitro resistance to dexamethasone of 
basophils from patients receiving, 1015 
-treated pu lmonary sarcoidosis, prediction of therapeutic re-
sponse in, 65 
(correspondence), 1139 
Sulfur oxide exposure, long-term ambient , prevalence of persistent 
cough and phlegm in young adults in relation to, 261 
Superoxide dismutase, l iposome-encapsulated, protection against 
pulmonary oxygen toxicity in rats by intratracheal admin-
istration of, 164 
Surfactant-deficient lambs, normal izat ion of arterial blood gases 
after t reatment of, with Tween 20, 1313 
Swallowing, effects of, on pat tern of continuous respiration in 
adults , 1219 
Syndrome 
acquired immune deficiency, utility of gallium-67 scintigraphy 
and bronchial washings in diagnosis and treatment of 
Pneumocystis carinii pneumonia in, 1087 
adult respiratory distress 
causes of mortali ty in pat ients with, 485 
chemotactic activity in bronchoalveolar lavage fluid from 
patients with, 490 
indicators of risk, course, and prognosis (editorial), 471 
neutral endopept idase in serum samples from patients with, 
compared with angiotensin-converting enzyme, 1262 
neutrophil elastase-releasing factors in bronchoalveolar lavage 
from patients with, 1098 
prognosis after onset, 472 
pulmonary extraction of serotonin and propranolol in patients 
with, 479 
regulation of tissue oxygen extraction is disturbed in, 109 
Systemic lupus erythematosus , shrinking lung, diaphragmatic 
dysfunction, and (case report) , 926 
" m T c D T P A , cigarette-smoke-induced changes in rat pulmonary 
clearance of, 1170 
Tetraplegia, relationship between respiratory muscle electromyogram 
and rib cage mot ion in, 53 
Theophylline 
responses to large doses of, in pat ients with C O P D , 871 
sustained-release, reduces dyspnea in nonreversible obstructive 
airway disease (correspondence), 195 
Thrombin-induced microembolism, pulmonary transvascular fluid 
and protein exchange after, 70 
Thromboxane synthetase inhibitor (OKY-046), selective, effects of, 
on endotoxin-induced lung injury in unanesthetized sheep, 
494 
Tissue 
distribution, influence of hypoxemia on, in conscious dog, 504 
lung 
connective, biochemical and pathologic evidence for proteo-
lytic destruction of, in cystic fibrosis, 529 
neutral metal loendopept idase in, 564 
oxygen extraction, regulation of, is disturbed in ARDS, 109 
shrinkage, lung, effects of 10% formalin fixation on, 1078 
Toluene diisocyanate 
airway hyperresponsiveness and inf lammat ion induced by, in 
guinea pigs, 1106 
prednisone inhibits late as thmat ic reactions and associated in-
crease in airway responsiveness induced by, 1010 
Trachea, increase in size of, with age, 784 
Transplantation, allogeneic bone marrow, diagnostic yield of bron-
choalveolar lavage in pneumoni t i s occurring after, 1118 
Trauma, cutaneous, and blastomycosis (correspondence), 931 
Trudeau medal for 1985, 719 
Tubercule bacilli within cultured h u m a n macrophages, effect of 
e thambutol on, 742 
Tuberculin 
conversions in Indochinese refugees, assessment of boosting and 
anergy in, 516 
skin testing, annua l , choosing appropr ia te cutting point for 
conversion in, 379 
test 
re-emphasis on clinical judgment (commentary) , 177 
variability with Mantoux procedure (commentary) , 175 
Tuberculosis 
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The Concentration of Leukocyte Elastase-ol-Proteinase Inhibitor Complex 
in Bronchoalveolar Lavage Fluids from Healthy Human Subjects 1 3 
MARIANNE JOCHUM, ANTOINE P E L L E T I E R , CHRISTIAN BOUDIER, G A B R I E L L E PAULI, and J O S E P H G. BIETH 
SUMMARY Although a1-proteinase inhibitor (a1-antitrypsin) is widely thought to protect lung elastin 
against the elastolytic action of leukocyte elastase, there is only circumstantial evidence for such 
a protective role. We have demonstrated and quantified elastase-ol-proteinase inhibitor complex 
in bronchoalveolar lavage fluids from healthy smokers and nonsmokers using a new enzyme-linked 
immunosorbent assay. The relative concentration of complex is 0 .36 ± 0.48 mmol/mol albumin 
in nonsmokers and 0 .33 ± 0 .29 mmol/mol albumin in smokers. Less than 1% of lavage fluid a1-
proteinase inhibitor is complexed with elastase (0 .31% in nonsmokers and 0 . 34% in smokers). This 
proportion is, however, much higher than in normal plasma where only approximately 0 . 0 0 6 % of 
inhibitor is bound to elastase. Our data confirm that a1-proteinase inhibitor efficiently acts as an 
antielastase barrier in the lower respiratory tract. AM REV RESPIR DIS 1985; 132:913-914 
The protease-antiprotease theory of pulmo-
nary emphysema holds that alveolar struc-
tures may be destroyed by proteases such as 
neutrophil elastase but are normally protected 
from destruction by elastase inhibitors such 
as al-proteinase inhibitor (a lPI ) . There is, 
however, only circumstantial evidence in fa-
vor of this theory. For instance, emphysema 
may be induced in animals with large doses 
of neutrophil elastase (1), and inherited defi-
ciency of a l P I is linked to a high frequency 
of this disease (2). By contrast, demonstra-
tion of elastase-alPI complex in the lower res-
piratory tract would provide direct evidence 
tha t elastase is released and inhibited at the 
alveolar level. Recently, 2 groups of investi-
gators have developed enzyme-linked im-
munosorbent assays for the quanti tat ion of 
human leukocyte elastase-alPI complexes (3, 
4). We therefore decided to use one of these 
methods (3) to measure the amount of 
elastase-alPI complex in bronchoalveolar la-
vage fluids from healthy human smokers and 
nonsmokers . 
The 17 lavage fluids used in this study are part 
of the 20 samples collected and described previ-
ously (5). Briefly, a B3 fibroscope (Olympus Corp. 
of America, New Hyde Park, NY) was wedged into 
the distal branch of the lingula, and five 60-ml por-
tions of saline were infused into the lung and re-
covered in a vacuum trap (mean recovery, 50 ± 
10%). The 5 samples were pooled, centrifuged, and 
frozen until used. After thawing, they were con-
centrated 5-fold by Amicon UM2 ultrafiltration 
(Amicon Corp., Lexington, MA). 
The mean age of the 8 nonsmokers and of the 
9 smokers was 27.8 ± 10.8 yr and 25 ± 2.9 yr, 
respectively. The smokers (smoking rate, 8.5 ± 4.9 
pack-years) did not smoke for at least 24 h before 
lavage. The nonsmokers' and the smokers' fluids 
contained 12.1 ± 7.2 x 106 and 28.7 ± 18.5 x 
106 alveolar macrophages and 0.28 ± 0.14 x 106 
and 0.28 ± 0.51 x 106 polymorphonuclear neu-
trophils per lavage, respectively. 
The elastase-crlPI concentration was determined 
on the concentrated fluids using the enzyme-linked 
immunosorbent assay described in detail by Neu-
mann and coworkers (6). Briefly, the samples were 
added to microtitration plates coated with sheep 
antielastase IgG. This antibody does not cross-react 
with cathepsin G and other neutrophil proteinases. 
After incubation and washing, the solid phase-
bound elastase-alPI complexes were reacted with 
alkaline phosphatase-labeled rabbit anti-alPI IgG. 
After further washings, p-nitrophenylphosphate 
was added to measure the amount of solid phase-
bound elastase-alPI complexes. The assay was 
calibrated using a standard solution of known 
elastase-alPI concentration. The preparation of this 
solution is described in detail in the report by Neu-
mann and coworkers (6). Calibration curves iden-
tical to those reported by these investigators were 
always obtained. To determine whether ultrafiltra-
tion impairs the measurement of elastase-alPI, we 
used 3 lavage fluids collected from polytraumatized 
patients, and we measured the concentration of 
complex before and after 5-fold fluid concentra-
tion by ultrafiltration (in these fluids the elastase-
alPI concentration was sufficiently high to allow 
the assay to be performed on unconcentrated sam-
ples). The 3 concentrations of complex expressed 
as microgram of elastase per milliliter of uncon-
centrated fluid, were 0.81, 1.04, 6.38, and 0.86, 1.01, 
6.14 before and after ultrafiltration, respectively. 
These data show that the concentration process does 
not significantly distort the data. 
All lavage fluids except 1 contained detect-
able amounts of elastase-alPI complex. The 
absolute concentrations ranged from 0 to 15.6 
ng elastase/ml in nonsmokers and from 0.6 
to 7 ng elastase/ml in smokers. The relative 
concentrations (mean ± SD) were 0.36 ± 0.48 
mmol e las tase-a lPI /mol albumin in non-
smokers and 0.33 ± 0.29 mmol elastase 
a l P I / m o l albumin in smokers. The relative 
concentrations of immunoreactive (total) a lPI 
were 88 ± 34 mmol a l P I / m o l albumin in 
nonsmokers and 92 ± 27 mmol a l P I / m o l 
albumin in smokers (5). Hence, the percent-
age of elastase-bound a l P I was 0.31 ± 0.31 
in nonsmokers and 0.34 ± 0.24 in smokers. 
The individual values obtained for the 2 
groups of subjects are shown in figure 1; this 
confirms that both relative concentrations of 
elastase-alPI complex are very scattered. 
Thus, smokers and nonsmokers have very 
similar levels of complex. In addition, the con-
centration of elastase-alPI complex does not 
significantly correlate with the smoking rate 
(pack-years) or with the concentration of poly-
morphonuclear leukocytes present in the la-
vage fluids. 
In vitro studies have shown that cigarette 
smoke condensate releases elastase from neu-
trophils (7). It is therefore surprising that the 
smokers did not have higher amounts of 
elastase-alPI complex than did the nonsmok-
ers. This might in part be due to the short 
smoking history of the volunteers (8.5 ± 4.9 
pack-years). It is also possible that some of 
the elastase-üTPI complexes formed during 
smoking disappeared from the lung surface 
during the 24-h nonsmoking period that 
preceded the smokers' lavages. Further experi-
ments are required to clarify this point. 
* * * 
The mean absolute concentration of com-
plexed elastase in the 17 samples is 4.2 ng/ml . 
Taking into account the mean volume of la-
vage fluids (150 ml), we get an average of ap-
proximately 600 ng of a l P I - b o u n d elastase 
per lavage. Because neutrophils contain about 
3.5 \xg elastase per 106 cells (8), the aforemen-
tioned amount of elastase corresponds to 0.17 
x 106 neutrophils, i.e., to 60% of the neu-
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Fig. 1 Relative concentrations of elastase-olPI complex 
(E-a1PI) in bronchoalveolar lavage fluids from 8 non-
smokers (NS) and 9 smokers (S). Horizontal bars indi-
cate mean values. A. The data are expressed relative 
to the concentration of albumin (5). Mean ± SD = 0.36 
± 0.48 mmol elastase-a1PI/mol albumin in nonsmok-
ers and 0.33 ± 0.29 mmol elastase-a1PI/mol albumin 
in smokers. B. The data are expressed relative to the 
concentration of immunoreactive (total) a1PI (5). Mean 
± SD = 0.31 ± 0.31% elastase-bound olPI in non-
smokers and 0.34 ± 0.24% elastase-bound alPI in 
smokers. 
trophils recovered per lavage in our popula-
tion of healthy subjects. The amount of 
elastase-alPI complex must therefore be con-
sidered as high despite the fact that it 
represents only 0 . 3 % of total a l P I . It must 
also be emphasized that in normal plasma 
only about 0.006% of a l P I is complexed to 
neutrophil elastase (4, 6). Our data therefore 
suggest that even in healthy persons there is 
massive liberation of neutrophil elastase in 
the lower respiratory tract and that a lP I effi-
ciently acts as an antielastase barrier. 
The present data also show that in vivo 
complex formation between a l P I and neu-
trophil elastase does not account for the high 
proportion of functionally inactive a lPI pres-
ent in lung lavage fluids (5). Other factors such 
as proteolytic degradation (9) might be 
responsible for the partial inactivity of a lP I . 
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